Evidence map›Paper›PMID 36520931›Full record

ArticlePloS one2022

Accurate and lightweight MRI super-resolution via multi-scale bidirectional fusion attention network.

Ling Xu, Guanyao Li, Qiaochuan Chen

Abstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ling XuTongji University, College of Electronics and Information Engineering, Jiading District, Shanghai, China.
Guanyao LiTongji University, College of Electronics and Information Engineering, Jiading District, Shanghai, China.ORCID 0000-0002-5853-6778
Qiaochuan ChenShanghai University, College of Computer Engineering and Science, Baoshan District, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-resolution magnetic resonance (MR) imaging has attracted much attention due to its contribution to clinical diagnoses and treatment. However, because of the interference of noise and the limitation of imaging equipment, it is expensive to generate a satisfactory image. Super-resolution (SR) is a technique that enhances an imaging system's resolution, which is effective and cost-efficient for MR imaging. In recent years, deep learning-based SR methods have made remarkable progress on natural images but not on medical images. Most existing medical images SR algorithms focus on the spatial information of a single image but ignore the temporal correlation between medical images sequence. We proposed two novel architectures for single medical image and sequential medical images, respectively. The multi-scale back-projection network (MSBPN) is constructed of several different scale back-projection units which consist of iterative up- and down-sampling layers. The multi-scale machine extracts different scale spatial information and strengthens the information fusion for a single image. Based on MSBPN, we proposed an accurate and lightweight Multi-Scale Bidirectional Fusion Attention Network(MSBFAN) that combines temporal information iteratively. That supplementary temporal information is extracted from the adjacent image sequence of the target image. The MSBFAN can effectively learn both the spatio-temporal dependencies and the iterative refinement process with only a lightweight number of parameters. Experimental results demonstrate that our MSBPN and MSBFAN are outperforming current SR methods in terms of reconstruction accuracy and parameter quantity of the model.

Indexed as

Image Processing, Computer-AssistedMagnetic Resonance ImagingAlgorithms

Identifiers

PMID36520931
PMCPMC9754592

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.